ReviewNature reviews. Drug discovery2023
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs.
Pavel Kolkhir et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
88 papers cite itlatest 60 shown
this paperpooled ittrialcites it